According to Hoth Therapeutics's latest financial reports the company's current EPS (TTM) is -$6.22. In 2022 the company made an earnings per share (EPS) of -$9.61 an increase over its 2021 EPS that were of -$16.53.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$6.22 | -35.28% |
2022 | -$9.61 | -41.86% |
2021 | -$16.53 | 14% |
2020 | -$14.50 | -30.12% |
2019 | -$20.75 | 213.46% |
2018 | -$6.62 |